KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Gilead Sciences (GILD) Intangibles (2016 - 2025)

Gilead Sciences (GILD) has disclosed Intangibles for 10 consecutive years, with $33.5 billion as the latest value for Q4 2021.

For the quarter ending Q4 2021, Intangibles changed N/A year-over-year to $33.5 billion, compared with a TTM value of $33.5 billion through Dec 2021, changed N/A, and an annual FY2021 reading of $33.5 billion, changed N/A over the prior year.
Intangibles was $33.5 billion for Q4 2021 at Gilead Sciences, down from $33.9 billion in the prior quarter.
Across five years, Intangibles topped out at $33.9 billion in Q3 2021 and bottomed at $13.8 billion in Q4 2019.
Average Intangibles over 3 years is $24.6 billion, with a median of $25.3 billion recorded in 2017.